OPKO Health (OPK) is back on investors’ radar after a recent move in its share price. This has prompted closer attention to ...

Opko enters into a $250 million non-dilutive note purchase agreement with HealthCare Royalty (HCRx). Opko says the purchase agreement is secured by its profit share payments from Pfizer received ...

OPKO Health, Inc. OPK is well-poised for growth in the coming quarters, supported by the potential of RAYALDEE. The optimism surrounding the stock is backed by RAYALDEE’s performance and strategic ...

OPKO Health (OPK) has been beaten down lately with too much selling pressure. While the stock has lost 24.3% over the past four weeks, there is light at the end of the tunnel as it is now in oversold ...

We recently compiled a list of the 10 Best Stocks Under $3 to Buy Now. In this article, we are going to take a look at where ...

The most recent short interest data was recently released by the NASDAQ for the 08/30/2013 settlement date, and Opko Health Inc (NYSE: OPK) is one of the most shorted stocks of the Russell 3000, based ...

OPKO Health, Inc. OPK posted earnings per share of 3 cents for the third quarter of 2025, flat year over year. Earnings beat the Zacks Consensus Estimate of a loss of 2 cents per share by 250.00%.

Investors in OPKO Health Inc (Symbol: OPK) saw new options become available today, for the December 3rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the OPK ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.